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Abstract
In most organisms, ABC transporters constitute one of the largest families of membrane proteins. In
humans, their functions are diverse and underpin numerous key physiological processes, as well as being
causative factors in a number of clinically relevant pathologies. Advances in our understanding of these
diseases have come about through combinations of genetic and protein biochemical investigations of these
transporters and the power of in vitro and in vivo investigations is helping to develop genotype–phenotype
understanding. However, the importance of ABC transporter research goes far beyond human biology;
microbial ABC transporters are of great interest in terms of understanding virulence and drug resistance and
industrial biotechnology researchers are exploring the potential of prokaryotic ABC exporters to increase the
capacity of synthetic biology systems. Plant ABC transporters play important roles in transport of hormones,
xenobiotics, metals and secondary metabolites, pathogen responses and numerous aspects of development,
all of which are important in the global food security area. For 3 days in Chester, this Biochemical Society
Focused Meeting brought together researchers with diverse experimental approaches and with different
fundamental questions, all of which are linked by the commonality of ABC transporters.
A brief history of ABC transporters
The ATP-binding cassette (ABC) transporter field emerged
from studies on nutrient uptake in bacteria in the 1970’s with
the biochemical characterization of substrate-binding protein
(SBP)-dependent transport systems energized directly by
hydrolysis of ATP [1]. The early 1980’s saw the cloning
of several genes encoding such transporters, spearheaded
by the histidine permease of Salmonella typhimurium and
maltose permease of Escherichia coli [2,3]. In parallel,
medical researchers were tracking down the gene encoding
permeability-glycoprotein/P-glycoprotein (P-gp), a large
glycosylated membrane protein associated with multi-drug
resistance in mammalian cells [4]. P-gp was eventually
cloned in 1985 [5] and with increasing availability of cDNA
sequences, it became apparent that both the mammalian and
the bacterial transporters contained highly conserved nt-
binding motifs (the Walker A and B sequences) [6], hinting at a
common evolutionary origin. In 1986, it was recognized that
these ATP-binding subunits defined a large superfamily of
transport proteins [7–10] although the term ABC transporter
was not actually coined until 1990 [11], by which time
it was became apparent that ABC transporters were not
only ubiquitous but also involved in diverse biochemical
and physiological processes. A timeline of key events
in the development of ABC transporter research is given in
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Figure 1 and a vivid account of the trials and tribulations
of characterizing one of the prototypical ABC transporters
(P-gp) is presented by Callaghan [12].
Genome sequencing, complemented by careful studies of
individual transporters, has revealed a common architecture
with a core ABC transporter comprising two nt-binding
domains (NBDs) and two transmembrane domains (TMDs),
often with additional domains. These domains are encoded
either as individual proteins (typically in prokaryotes)
or in varying degrees of fusion, with eukaryotic ABC
proteins largely expressed as so-called ‘half-size’ (TMD–
NBD or NBD–TMD) or ‘full-size’ (TMD–NBD–TMD–
NBD or NBD–TMD–NBD–TMD) transporters (Figure 2)
[13]. Domain organization and phylogenetic analysis have
defined eight major subfamilies of eukaryotic ABC proteins,
two of which (E and F) are not membrane associated and
have functions other than transport [14,15]. Intriguingly, the
ABC family includes both ‘exporters’ and ‘importers’ [16]
(Figure 2). Importers, which typically rely on periplasmic
SBPs to deliver substrates to the transporter core, were con-
sidered to be restricted to prokaryotes (and, rarely, organelles
of endosymbiotic origin) but exporters are common to all
kingdoms [15–17]. Previously, the discovery of a group of
prokaryotic micronutrient uptake transporters dependent on
ABC transporter NBDs but without extracytoplasmic SBPs
(the energy coupling factor ABC transporters) has further
extended the repertoire of ABC transporter architecture [18].
Diversity of function: linking physiology
with biochemistry
The functions of ABC proteins are too numerous to
catalogue in detail here, but it is well established that they
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Figure 1 Timeline showing selected key discoveries and events in ABC research
transport a huge range of diverse substrates, from simple
ions, through polar, amphipathic and hydrophobic organic
molecules to peptides, complex lipids and even small proteins.
Consequently, ABC transporters are implicated in a wide
array of developmental processes [14,15,17,19]. Plants have
the largest complement of ABC proteins of all eukaryotes
[15,19] and it was fitting that the meeting opened with
a session devoted to diversity of function headlined by
Enrico Martinoia [20], who described the roles of plant
ABC transporters in phytohormone transport. The ABC
superfamily expanded dramatically with the conquest of
land by plants, associated in part with their sessile nature,
multi-cellularity and extensive capacity for synthesis of
secondary chemicals. It has long been hypothesized that
plant ABC transporters would be involved in the synthesis
and deposition of secondary metabolites (from which many
important drugs are derived), but an important discovery
has been the implication of subfamily G transporters in the
transport of several major classes of plant hormones, namely:
auxins, cytokinins, abscisic acid and the recently-discovered
strigolactones [20]. Intriguingly, Martinoia and colleagues
[19,20] drew attention to the increasing number of reports
in the literature suggesting that both plant ABCGs and
ABCBs can act as importers, challenging the ‘exporters only’
adage for eukaryotic ABC transporters (Figure 2). Much of
this evidence is phenomenological and requires confirmation
in vitro but perhaps the most convincing example is
Arabidopsis ABCB14, which mediates malate uptake when
expressed in E.coli and HeLa cells [21]. The ability of plant
(and yeast) ABC research to make us rethink paradigms
was also highlighted by Alison Baker and colleagues [22,23],
who presented a novel mechanism for peroxisomal fatty
acyl-CoA import by ABCD proteins, involving substrate
cleavage catalysed by a thioesterase activity intrinsic to the
transporter, followed by re-esterification by acyl activating
enzymes which form a complex with the transporter in the
peroxisomal lumen.
Much information about the roles of ABC transporters
has been deduced using loss of function mutants isolated in
genetic screens [20] and the pressing need for complementary
biochemical studies of plant ABC transporters was outlined
by Franc¸ois Lefe`vre, using ABC sub-class G as an
exemplar [24]. Some plant ABC transporters have been
identified in multiple genetic screens and have been ascribed
several different biochemical functions, based on their
apparently disparate physiological roles. How do you go
about characterizing a transporter when the identity of
the transport substrate (or substrates) is not immediately
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Figure 2 Domain organization of ABC transporters from different organisms
In Gram-negative bacteria, importers comprise two TMDs, two NBDs (ATPase subunits) and a periplasmic SBP. In Gram-positive
bacteria and archaea which have no outer membrane, SBPs are anchored to the extracellular face of the cytoplasmic
membrane, or to the TMDs (not shown). Energy coupling factor (ECF) transporters comprise two ATPase subunits, a
transmembrane protein (T) and a substrate-speciﬁc integral membrane protein (S). All bacteria and archaea also contain
homo- or heterodimeric exporters, in which a TMD is fused with an NBD. Eukaryotic ABC proteins are classiﬁed in eight
subfamilies (A–H). The organization of core and additional domains is shown for different representative topologies in
each subfamily; transporters discussed in this volume are indicated in bold. Not included are soluble subfamilies E and
F and transporter subfamily H, which is absent from mammals, plants and fungi. Plant genomes also encode several
‘prokaryotic-like’ ABC transporters, designated subfamily I, which have been acquired via the endosymbiotic origin of
mitochondria and plastids [15] (not shown).
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Table 1 ABC transporters associated with human health and disease
References cited are from relevant papers in this Special Issue.
ABC transporter Disease References
ABCA1 Tangier disease and familial high density lipoprotein (HDL) deﬁciency;
atherosclerosis; Alzheimer’s disease
[38]
ABCA3 Neonatal surfactant deﬁciency and pulmonary ﬁbrosis; congenital cataract [37]
ABCA4 Stargardt macular degeneration
ABCA7 Alzheimer’s disease [38]
ABCA12 Harlequin and lamellar ichthyosis
ABCB1/transporter associated with antigen
processing (Tap)2; ABCB2/Tap1
Immune deﬁciency; arthritis risk
ABCB4/MDR2 PFIC3; other types of cholestasis [39]
ABCB7 Sideroblastic amaemia and ataxia [26]
ABCB11/bile salt export pump (BSEP) PFIC2; intrahepatic cholestasis of pregnancy; neonatal respiratory distress
syndrome
[39]
ABCC2/MRP2 Dubin–Johnson syndrome
ABCC5/MRP5 Inherited hypertrichosis
ABCC6/MRP6 Pseudoxanthoma elasticum
ABCC7/CFTR CF [30,31]
ABCC8/SUR1 Diabetes [35]
ABCC9/SUR2 Diabetes [35]
ABCD1/adrenoleukodystrophy protein (ALDP) X-linked adrenoleukodystrophy [23,45]
X-linked adrenomyeloneuropathy
ABCD3/peroxisome membrane protein (PMP70) Hepatosplenomegaly; liver disease [23,45]
ABCD4/PMP69 Inborn error of vitamin B12 metabolism [23]
ABCG2/breast cancer resistance protein (BCRP) Gout and hyperuricaemia
ABCG5; ABCG8 Sitosterolemia; coronary heart disease; gallstone disease
ABCB1/P-gp; ABCC1/MRP1, ABCG2/BCRP Multi-drug resistance [12,44,45]
ABCC2-6 Drug transport
obvious? An interesting approach to this question was
provided by Janneke Balk and colleagues [25], who used a
LC–MS metabolomic approach [26] to identify glutathione
polysulfides as likely physiological substrates for Arabidopsis
ABCB25/ABC transporter of mitochondria 3 (ATM3), a
mitochondrial ABC transporter involved in iron-sulfur
cluster and molybdenum cofactor assembly. Importantly, the
physiological relevance of the transport studies was verified
by follow-up genetic experiments [25,27]. Also exploring the
functions of ABC transporters in redox processes, Mark
Shepherd [28] proposed a role for the CydDC complex
of E. coli in redox sensing and NO tolerance. CydDC
exports cysteine and glutathione to the periplasm but is
also thought to bind haem on the periplasmic surface which
stimulates reductant export and may interact with gaseous
signalling molecules, suggesting a novel virulence mechanism
for bacteria.
ABC transporters in health and disease:
from bench to bedside and back again
As in plants and microbes, the importance of human ABC
proteins and the diversity of their physiological roles are
underscored by the consequences of their dysfunction. To
date, over 20 ABC proteins, representing all sub-families
have been associated with human disease (Table 1) and several
others play clinically important roles in drug metabolism and
resistance.
It is now over 25 years since the causative gene in cystic
fibrosis (CF) was identified as ABCC7 [also known as the CF
transmembrane conductance regulator (CFTR)] [29] and a
huge wealth of information has been obtained for this atypical
ABC protein which is not in fact a primary active transporter
but an ATP-gated chloride channel. David Sheppard
emphasized the importance of understanding how different
mutations affect CFTR function for the development of
chemical correctors and discusses together with Pollock et
al. [30,31] in this volume how species differences can be
exploited to understand CFTR structure and function. To
date, over 2000 mutations have been associated with CF [30],
some of which affect key phosphorylation sites of CFTR
[32]. Bibek Aryal [33] presented novel examples of ABC
transporter regulation by phosphorylation and in this special
issue, draws intriguing parallels between phosphorylation of
the CFTR regulatory domain and phosphorylation of the
linker region in plant ABCB transporters. The sulfonylurea
receptors (SUR1/ABCC8; SUR2/ABCC9) are also atypical
ABC proteins; by forming a hetero-octameric complex with
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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potassium channel Kir6.2 subunits they produce the ATP-
sensitive potassium channel whose activity is critical for
insulin secretion [34,35]. Heidi de Wet [35] explained the
complex mechanism of channel inhibition by sulfonylureas
using elegant electrophysiological approaches and examined
implications for treatment of neonatal diabetes.
A recurring theme of the meeting was the need for
combinations of techniques to understand ABC trans-
porter function/mis-function and role in physiology/disease,
particularly for rare disorders and diseases with complex
aetiologies. The involvement of ABCG2 in pre-disposition to
gout is familiar to many in the ABC transporter community
[36], but here we heard about studies implicating two
members of the ABCA subfamily in disease. Andrea Masotti
[37] outlined the challenges in diagnosing a spectrum of rare
disorders of the surfactant system linked to mutations in
the gene encoding the lung specific phospholipid transporter
ABCA3 and Brett Garner [38] described how ABCA7 was
identified as a genetic risk factor in late-onset Alzheimer’s
disease, presenting recent work with mouse and cell-based
disease models to understand the function of ABCA7 in
this context. The multi-disciplinary theme was continued
by John Schuetz and Kenny Linton [39] who described
work characterizing ABC transporters in liver disease. Owing
to a combination of biochemistry, physiology, genetics
and clinical science, the roles of three transporters: lipid
floppase, ABCB4, bile salt export pump, ABCB11 and the
P-type ATPase, ATP8B1 in progressive familial intrahepatic
cholestasis (PFIC) are now well understood [39]. Animal
models, particularly mouse models, have been extremely
instructive in elucidating the functions of human ABC
transporters but there is often a marked inconsistency
between human and mouse pathologies, for example in CF
and X-linked adrenoleukodystrophy [30,40]. In the case
of cholestatic disease, this has proved informative, since
transporter function could be studied in abcb11 knockout
mice without the development of secondary pathology
but this disparity also emphasizes the importance and
utility of studying the biochemistry of recombinant human
ABCs [39].
In addition to roles associated with endogenous substrates,
several ABC transporters are known to show relatively
limited substrate specificity. This multi-drug transport
capability is well established for ABCB1, ABCC1 and
ABCG2 (and new drugs must be tested as transport substrates
of these three promiscuous pumps) [41]. Two clinical
correlates of multi-drug transport were explored: the first
was the role ABC transporters play in drug metabolism.
Andrew Owen [42,43] described mathematical approaches in
pharmacokinetics (PK), contrasting population PK (starting
with clinical data and fitting a model) with physiological
PK (predicting clinical outcome from models of transport
data). Such PK models can already be used to simulate
different treatment regimens and predict how they might
work for patients with different transporter SNPs (single-nt
polymorphisms) [42,43]. Secondly, multi-drug transporters
are partially responsible for cancer drug resistance, which
causes tens of thousands of cancer deaths each year.
The possibility of specifically targeting cancer stem cells
expressing multi-drug pumps (e.g. ABCB1) was described
by Beth Coyle [44]. By repurposing a hypertension drug,
Vardenafil, inhibition of ABCB1-mediated drug resistance
was achieved in cell lines established from difficult to treat
children’s brain tumours. Intriguingly, Vardenafil may not
only overcome one particular challenge to brain tumour
chemotherapy since it crosses the blood–brain barrier, but
its inhibition of ABCB1 may also have a collateral benefit
in reducing dissemination and invasion of drug resistant
tumour cells [44]. Although ABCB1, C1 and G2 are
the three usual suspects in multi-drug resistance, other
ABC transporters also play roles in drug metabolism and
beyond in cancer biology [41]. In this context, Viktor Hlava´cˇ
[45] presented emerging evidence for differential regulation of
sub-class D ABC transporters associated with both positive
and negative outcomes in diverse cancers.
Structure and mechanism: an ideal pas de
deux?
Visualizing the structure of ABC transporters at atomic
resolution has become something of a holy grail in the field
but an understanding of their dynamics is equally important
[46]. Ironically, the first ABC-related structure of a soluble
SBP was published 10 years before the ABC transporter
family was defined [47]. Although many crystal structures
have followed and SBPs are the best understood components
of ABC transporters, they still hold a few surprises. Gavin
Thomas [48] elegantly elucidated the molecular basis of
substrate specificity in previously uncharacterized E. coli
SBPs. Liganded crystals not only identified unexpected
substrates but also revealed how the specificity can be
changed dramatically by a single alteration in a residue
distant to the binding site. Thorben Cordes followed with
a fascinating presentation of mechanistic detail derived from
single-molecule FRET studies of SBPs, challenging the
classical ‘Venus Flytrap’ model [49,50].
Although important 3D insights have been obtained from
EM and single particle analysis of full-length membrane
transporters [51,52], high-resolution ABC crystal structures
have been eagerly awaited. Membrane proteins are notori-
ously challenging for structural studies, the first task being to
produce pure, preferably active protein; an appreciation of the
magnitude of this undertaking is evident when considering
the huge worldwide effort that has gone into characterizing P-
gp [12] and the difficulties in heterologous expression of many
plant ABC transporters [24]. In this context, Naomi Pollock
[31] outlined different approaches to preparing recombinant
CFTR for structural studies, emphasizing the importance of
testing orthologues from different species and optimization
of detergent solubilization [31]. Perhaps unsurprisingly,
most structures obtained to date are of prokaryotic ABC
transporters which are generally easier to express and purify
in quantities amenable to crystallization, reviewed here by
c© 2015 Authors. This is an open access article published by Portland Press Limited and distributed under the Creative Commons Attribution Licence 3.0.
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Kostas Beis [53], who presented a synthesis of structural and
biophysical data for the anti-bacterial peptide transporter,
McjD at the meeting.
Liz Carpenter [54] highlighted a different problem
frequently faced by structural biologists that the proteins
which crystallize most readily are not necessarily those
for which functional information is available. ABCB10 was
the first human ABC transporter to produce diffracting
crystals in a structural genomics project but its precise
function remains frustratingly obscure [25,54]. Although
high resolution crystal structures of orphan transporters
are helpful for generating homology models and can give
insights into different conformational states, their utility is
greatly enhanced when the substrates are known and where
complementary biochemical or biophysical data are available.
An armoury of complementary approaches is now
available to probe ABC transporter structure and mechanism
and these can be particularly powerful when combined. For
example, van Veen discussed the use of cysteine-reactive
fluorescent reagents to investigate the catalytic cycle of MsbA
in the framework of crystal structures [55] and Fraser Mac-
millan [46,56] used P-gp to explain how EPR spectroscopy
can be employed in combination with site-directed spin
labelling to measure distances and probe accessibility in ABC
transporters. Where structures are available, MD simulations,
together with homology modelling, offer the possibility to
describe conformational dynamics, albeit over short time
scales. Laura Domicevica and Philip Biggin [57] presented
an analysis of P-gp drug binding using homology modelling
with MD and Thomas Stockner [46] discuss here how EPR
and MD can be combined to investigate the conformational
flexibility of ABC transporters, comparing dynamic data
for MsbA and P-gp with mechanistic predictions from
crystal structures in different conformations. A promising
complementary technique was introduced by Bavro [58]; X-
ray radiolytic footprinting combined MS (XF–MS) though
not yet applied to ABC transporters, offers valuable insights
into the dynamics of membrane proteins; in particular
XF–MS permits identification of structural waters and
conformational changes in proteins and is applicable to
protein complexes, which will interest many members of the
ABC transport community.
Conclusions and perspectives: whither
ABCs?
In 40 years, ABC transporter research has evolved into a
diverse, dynamic field with activity focused on both basic
and translational issues. The meeting brought home how
these extremes can inform and complement each other and
how biochemistry and genetics are still very much at the
heart of ABC transporter research. Much remains still to be
discovered, encapsulated by two major questions:
1) What do all those transporters do? In medicine, GWAS
(genome-wide association studies) and exome sequencing are
likely to reveal ABC involvement in even more medical
conditions, particularly rare diseases, whereas in yeast,
bacteria and plants, forward genetic and chemical screens are
predicted to uncover new functions for ABC transporters.
Identifying substrates for these ‘orphan’ transporters will
remain a major challenge as it has been for the g-protein
coupled receptor community.
2) How do they all work? Emerging techniques have much
to offer the field, including new methods for purification
and reconstitution [59], single molecule and single liposome
approaches [50,60,61], oxidative footprinting [58] and
subnanometer cryoelectron microscopy [62]. Although we
remain tantalized by the prospect of a series of high-
resolution liganded stuctures in states comprising the entire
catalytic cycle, with accompanying biophysical data, we
should remain sanguine and appreciate that a single unifying
mechanistic model of transport may not apply to this diverse
family of intriguing proteins.
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